Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2018 Jan-Feb;24(1):12-17.
doi: 10.4103/sjg.SJG_237_17.

Sarcopenia and risk of nonalcoholic fatty liver disease: A meta-analysis

Karn Wijarnpreecha  1 , Panadeekarn Panjawatanan  2 , Charat Thongprayoon  1 , Veeravich Jaruvongvanich  3 , Patompong Ungprasert  4
Affiliations
Review

Sarcopenia and risk of nonalcoholic fatty liver disease: A meta-analysis

Karn Wijarnpreecha et al. Saudi J Gastroenterol. 2018 Jan-Feb.

Abstract

Background/aim: The association between sarcopenia and nonalcoholic fatty liver disease (NAFLD) has been suggested by recent epidemiological studies, although the results have been inconsistent. This meta-analysis was conducted to summarize all available data and estimate the risk of NAFLD among patients with sarcopenia.

Materials and methods: A comprehensive literature review was conducted using MEDLINE and EMBASE databases through November 2016 to identify all studies that compared the risk of NAFLD among patients with sarcopenia versus those without sarcopenia. Effect estimates from each study were extracted and combined using the random-effect, generic inverse variance method of DerSimonian and Laird.

Results: Five cross-sectional studies with 27,804 participants met the eligibility criteria and were included in the meta-analysis. The risk of NAFLD in patients with sarcopenia was significantly higher than those without sarcopenia with the pooled odds ratio of 1.54 (95% confidence interval, 1.05-2.26). The statistical heterogeneity was high with an I2of 83%.

Conclusions: A significantly increased risk of NAFLD among patients with sarcopenia was observed in this study.

Keywords: Low muscle mass; meta-analysis; nonalcoholic fatty liver disease; nonalcoholic steatohepatitis; sarcopenia.

PubMed Disclaimer

Conflict of interest statement

There are no conflicts of interest.

Figures

Figure 1
Figure 1
Literature review process
Figure 2
Figure 2
Forest plot
Figure 3
Figure 3
Funnel plot
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Cruz-Jentoft AJ, Baeyens JP, Bauer JM, Boirie Y, Cederholm T, Landi F, et al. Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People. Age Ageing. 2010;39:412–23. - PMC - PubMed
    1. Janssen I. The epidemiology of sarcopenia. Clin Geriatr Med. 2011;27:355–63. - PubMed
    1. Baumgartner RN, Waters DL, Gallagher D, Morley JE, Garry PJ. Predictors of skeletal muscle mass in elderly men and women. Mech Ageing Dev. 1999;107:123–36. - PubMed
    1. Lindle RS, Metter EJ, Lynch NA, Fleg JL, Fozard JL, Tobin J, et al. Age and gender comparisons of muscle strength in 654 women and men aged 20-93 yr. J Appl Physiol. 1997;83:1581–7. - PubMed
    1. Janssen I. Influence of sarcopenia on the development of physical disability: The Cardiovascular Health Study. J Am Geriatr Soc. 2006;54:56–62. - PubMed